(Q24321356)

UDP glucuronosyltransferase family 1 member A6

1 reference

UDP glucuronosyltransferase family 2 member B15

1 reference

UDP glucuronosyltransferase family 1 member A9

1 reference

UDP glucuronosyltransferase family 2 member B17

1 reference

UDP glucuronosyltransferase family 1 member A1

1 reference

UDP glucuronosyltransferase family 2 member B7

1 reference

UDP glucuronosyltransferase family 1 member A4

1 reference

cellular glucuronidation

1 reference

liquid chromatography-tandem mass spectrometry

1 reference

4

Pierre Marquet

0 references

author name string

Anne-Laure Gagez

1

0 references

Koukeb Rouguieg-Malki

2

0 references

François-Ludovic Sauvage

3

0 references

Nicolas Picard

describes a project that uses

5

0 references

language of work or name

English

0 references

publication date

1 August 2012

0 references

published in

Analytical Biochemistry

0 references

volume

427

0 references

issue

1

0 references

page(s)

52-9

0 references

liquid chromatography-tandem mass spectrometry

1 reference

In vitro LC-MS cocktail assays to simultaneously determine human cytochrome P450 activities

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic acid in the liver

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Validated assay for studying activity profiles of human liver UGTs after drug exposure: inhibition and induction studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Glucuronidation of fenamates: kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and 2B7.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

The UGT1A1*28 polymorphism correlates with erlotinib's effect on SN-38 glucuronidation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Determination of UDP-glucuronosyltransferase UGT2B7 activity in human liver microsomes by ultra-performance liquid chromatography with MS detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Isoform-selective probe substrates for in vitro studies of human UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Characterization of bropirimine O-glucuronidation in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Isoflavones modulate the glucuronidation of estradiol in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Limited influence of UGT1A1*28 and no effect of UGT2B7*2 polymorphisms on UGT1A1 or UGT2B7 activities and protein expression in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Glucuronidation of Etoposide in Human Liver Microsomes Is Specifically Catalyzed by UDP-Glucuronosyltransferase 1A1

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Novel polymorphic human UDP-glucuronosyltransferase 2A3: cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Human UDP-glucuronosyltransferases: metabolism, expression, and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021

UGT genomic diversity: beyond gene duplication

1 reference

https://api.crossref.org/works/10.1016%2FJ.AB.2012.04.031

7 January 2021